chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigued; Have a lot of pain in their left calf of their leg - very sore to the touch; This is a spontaneous report received from a contactable consumer (patient's husband).  An adult female patient received BNT162B2 (BNT162B2), administered in arm right, administration date 19Mar2021 13:45 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 22Mar2021 12:00, outcome "not recovered", described as "Fatigued"; PAIN IN EXTREMITY (non-serious) with onset 22Mar2021 12:00, outcome "not recovered", described as "Have a lot of pain in their left calf of their leg - very sore to the touch". Therapeutic measures were not taken as a result of fatigue, pain in extremity.  Additional Information: The patient and her husband both had the first Pfizer COVID-19 vaccine dose last Friday. They were both very fatigued and have a lot of pain in their left calf of their leg - very sore to the touch. These symptoms started on Monday of this week (22Mar2021).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021351681 Same reporter, product, and event; different patient
Fever 102; severe arm pain from neck to wrist; fatigue; muscle aches; headache; metal taste; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 09:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medication were reported as no. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown) via an unspecified route of administration in the left arm on 03Mar2021 at 10:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient reported that there were no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not tested for COVID-19. On 24Mar2021 at 22:00, the patient experienced fever 102, severe arm pain from neck to wrist, fatigue, muscle aches, headache and metal taste. The patients relevant tests included body temperature on 24Mar2021 and the result was 102-degree F. No treatment was received for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of fever 102, severe arm pain from neck to wrist, fatigue, muscle aches, headache and metal taste were resolving at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
1 day after administration-arm pain, swelling, redness. Chills and fatigue. Duration for 2-3 days.
Began with right side head pain, tingling up the back of head on left and right. Tingling going around scalp. Fever that night and next day of 101. During first night tingling and pressure going to right side of top of head waking me out of sleep.  Tingling continued days and weeks and now months.  Strong and frequent at first for a few weeks and subsiding and returning at least once a week. Still continuing as of this date.  Reported to family doctor at last physical in August 2021.
Rapid heartbeat in short bursts for 5-30 seconds at a time. Got worse toward evening. Clocked at 140 beats per minute when it went long enough I could measure it.  Same thing the next day.
This spontaneous report was received from a doctor of pharmacy concerning a male patient of unknown age. On 20-JUN-2013, the patient was vaccinated with an expired dose of M-M-R II (lot number and expiry date reported as 0851AA and 03-JUN-2013 respectively), subcutaneously. No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Had COVID after primary series; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Had COVID after primary series) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Had COVID after primary series). At the time of the report, COVID-19 (Had COVID after primary series) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. Company comment:This spontaneous case is concerning a patient of unknown age and gender with no medical history reported, who received mRNA-1273 vaccine on an unknown date, experienced the unexpected, AESI of COVID-19. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. The outcome was reported unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.     Reporter did not allow further contact; Sender's Comments: This spontaneous case is concerning a patient of unknown age and gender with no medical history reported, who received mRNA-1273 vaccine on an unknown date, experienced the unexpected, AESI of COVID-19. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. The outcome was reported unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Abdominal pain, nausea, headache, weakness, fatigue, cold sweats with activity.
A couple of days after receiving my second dose, I started to feel like I was having a fibromyalgia flare. I started to have pains all through my body and felt fatigued. My doctors changed up some of my dosages and medications to try and calm the pain.
Feeling more tired than usual, weakness all over and slight fever. On 06/07/23 put her feet down to get out of bed and they just collapsed under her. She called for help and was taken to Hospital where they did a battery of tests and nothing came up as unusual. We took her home with a slightly elevated temperature of 99.9 gave her advil after lunch. By that evening she felt a little better. This morning on 6/8/23 she was feeling a little more energetic, hungry, etc but still weaker than normal but better than the day before. She is being more careful after her initial fall and hospital visit trying to drink more water and o be mindful of the previous day not to repeat.
Injection site reactions: pain, swelling, stiffness of arm General side effects: fatigue, headache, chills, nausea The night of the vaccine I was already feeling soreness in my arm, which I had expected, and that night I took three medications: my nightly Escitalopram, ibuprofen 600mg, and a OTC sleep aid diphenhydramine HCI 50mg. The sleep aid did not help as I only slept a few hours but could not stay asleep due to the pain. I woke up at 7 AM to feed my cat, then tried to lay back down, but was unable to. I went to the toilet feeling nauseous and wretched a few times but did not throw up. I did, however, experience diarrhea that morning and throughout the day. I laid down on the couch and fell in and out of sleep for a few hours. I felt the headache most of the morning, until about 11 AM,. I felt the chills throughout most of the day. I treated my pain with ibuprofen 200mg tablets (3 taken each time, 4-6 hours apart), Pepto-bismol for the nausea and had mostly liquids such as water and juice as well as bread and crackers. I felt much better by around 2 PM, except for the tenderness and swelling in my arm.
Chills, fever 101.9 F, back pain, fatigue, itching bumps on my elbow and knees, needles under my right arm. I am taking Tylenol every 6h.
pt recvd vax;24 hrs later, devel cellulitis at inject site;
Pt recv vax on 3/26/99; on 4/4/99 pt exp macular papular rash on body & head, clear nasal drainage, cough; tx=Atarax, bath in Aveeno powder
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), on 16Nov2021 at 10:00 as dose 3 (booster), single (Lot number: FF8829) at the age of 36 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HIV currently undetectable" (unspecified if ongoing), notes: HIV currently undetectable; "On therapy for TB exposure" (unspecified if ongoing), notes: On therapy for TB exposure; "Known allergies: Plums" (unspecified if ongoing), notes: Known allergies: Plums. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: Based on the available information in the case, the causal association between the events COVID-19 and DRUG INEFFECTIVE and the suspect drug BNT162B2 cannot be excluded.
Pt. states vaccine site very painful with increasing pain starting with discomfort up after shot with very painful about 2 days later. Site is painful to the touch but not warm, swollen or red. Pt states it is very painful to raise arm in certain positions and cannot remove shirt without assistance. No report of fever.
Aprox.  10 min after immunizations, patient had Urticarial hyper rash on abdomen, Lt. arm and back.  2 new spots were noted after 20 minutes of close observation.   ORAPRED given along with a prescription for ATARAX.
Itching and redness at injection site. Applied anti itch cream. 25mg Benadryl orally.
within one hour: redness in toes, numbness and tingling in both hands and both feet Within six hours: severe headaches  Left leg pain from pinky toe to butt-outer leg and back of leg, difficulty walking especially going from sitting to standing and going up and down stairs.
Immediate atypical syncopal event, followed by another syncopal event after usual treatment and recovery proceedings; Sent to ER for weakness, dizziness, had another a-typical event striking head on the gurney. No previous history of such, no previous vaccine reaction or history of syncope. ECG SR with pauses noted, that resolved.
After recieving the Moderna immunocompromised booster vaccination on Sat 22 Jan 2022, I was not feeling well throughout the next several days.  I had a previously scheduled followup appointment with my oncologist, at medical center on 28 Jan 2022.  Typically, these appointments assess blood CBC and CMP.  Dr. noted several anomolies on the blood test results - extremely low platet counts (24) and extremely high liver enzyme values.  We discussed a potential adverse reaction to the Moderna vacination that she could not rule out as a possible cause.  We agreed that these results compelled treatment for graft vs host disease (GVHD).   Substantial followup visits and numerous pharmaceutics Substantial pharmacuetics added to my daily regimine to treat for potential GVHD including steriods (predisone), immunosuppression (Jakafi), bactrim (sulfamethoxazole and, pantoprazole.  At the time of this report, my CBC and CMP are trending to normal, some of the pharmaceutics (e.g. steroids) have been tapered (30mg to 10mg).  Regardless, I continue to need to have a high level of physician care over since administration of the Moderna Vaccine.
First day post vaccine tenderness at site, second day warmth and redness developed in right upper arm around and below injection site.  Not painful but tends to be mildly itchy .  Redness darker in AM .   Have not contacted primary yet unless condition worsens.
Fever, rash at face, arms, legs and trunk for 4 days. Tx Tylenol. Fine 2 mm pinhead vesicular rash with centripetal distribution.
Pt seen in office 11/16/09. Mother states baby received vaccines on 11/6/09 and since then  baby has had constant lateral motion/jerking of head and is not vocalizing as she used to. Appointment set up with neurologist for 11/19/09.
a few minutes after vaccination, the pt reported that they weren't feeling well. he was seated with his head near his knees. I applied a cold pack to the back of his neck as he was sweating heavily. he stayed this way for about 20 minutes until he felt better and was able to walk out.
runny nose, pink sclera (OD), rash spreading from face & ears to trunk & extremities becoming hives w/swollen lips/feet; given DPH w/relief of most sx;
Preventative - ER vaccination. Pre-medicated with SOLUMEDROL 12.5mg IVP x2, BENADRYL 75mg IVP x1. Still itchy x 2 1/2 days. 2 BENADRYL 50-75mg po every 6 hrs. Rec'd ZOFRAN 4mg IVP x1 for nausea R/T BENADRYL.
I had shortness of breath body aches headaches and also coughing and minor wheezing. I was prescribed Paxlovid today 09/15/2022 by my doctor via telehealth.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 22Apr2022 as dose 4 (booster), single (Lot number: FK9893) at the age of 50 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1,single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: BYSTOLIC, start date: 01Jan2021; GEMTESA, start date: 01Jan2022; SINGULAIR, start date: 01Jan2021. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", SUSPECTED COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Clinical course: Patient received antiviral treatment for COVID-19. No known allergies and no other medical history.
6 am following day (4/6) after injection on 4/5/21, my 17-year-old daughter complained of sore right arm (injection site), tinnitus, syncope, nausea, fever. Day before had also been treated for vaginal yeast infection. Treated with miconazole and fluconazole (tablet and vaginal cream). Also complained that her ovaries hurt.  She self-administered Motrin and applied heat. Went back to bed. Has rested without waking, suspect fatigue as well.
Narrative: COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/08, Pfizer, dose #2 08/07 pt cc: cough, rhinorrhea, fatigue, dyspnea, myalgias, nasal congestion exposure: unknown 08/09 COVID swab, result: detected 08/09 SARS-COV-2 Variant Sequencing result: pending 08/17 clinically resolved
I started having whole body hives which is like your body is like burning and itching; I started having whole body hives which is like your body is like burning and itching; I started having whole body hives which is like your body is like burning and itching; I am having this allergy; My skin has rashes and it is red and itchy; My skin has rashes and it is red and itchy; So, then after my second vaccination, I started to have it much often; After this vaccination my system went very down; I am scared to die after this vaccination; I can't work right now; This is a spontaneous report received from a contactable consumer (patient).A 31-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on 19Apr2021 (Batch/Lot Number: EW0170) as 2nd dose, single for covid-19 immunization.The patient received first dose of BNT162 (PFIZ-ER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: ER8730, Expiration date: unknown), via unspecified route of administration on 22Mar2021 as 1st dose, single for covid-19 immunization.Medical history included on 28 March, the patient started to have hives on whole body and it was anytime, it was like at night ,like your body is like burning and itching, it got worse almost everyday and patient having this allergy. Concomitant medications were not reported. On an unspecified date after the second dose, patient started to have it much often, woke up with few little on my face and cannot work right now. It was reported that nothing really helped, not even allergy medicine (Benadryl). After this vaccination the patient's system went very down and she was scared to die after this vaccination. The patient's skin has rashes, and it was red and itchy. It was reported that patient got two doses and three days after her first dose, she started having whole body hives which is like your body is like burning and itching. So, then after second vaccination, she started to have it much often and today and woke up with few little on my face which (voice not clear). She cannot work right now and cannot contact her physician, and nothing really helped, not even her allergy medicine (Benadryl) and never ever had this before the vaccination. The patient further stated she need to report and need some help because she was scared to die after this vaccination. Her skin has rashes and it is red and itchy, she need to go doctor because it was very dangerous from allergy you can literally die and she cannot go because the doctor was out of country and it was very difficult to go out of this country right now. The outcome of events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Cellulitis at the injection site; A spontaneous report was received from a nurse concerning a female patient of unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events cellulitis at the injection (Vaccination site cellulitis).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unspecified date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unspecified date, after vaccination the patient diagnosed with possible cellulitis at the injection site since it was swollen, red, and had a temperature of 99.8 F. Treatment details included Keflex for 10 days  Action taken with mRNA-1273 in response to the event was unknown.   The outcome of event, cellulitis at the injection site was considered as unknown .; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product and the start date of the reported events, and excluding any other etiology, a causal relationship with the event cannot be excluded
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced MYALGIA (Sore arm). At the time of the report, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment medication reported.
Mother delivered 4th child vaginally on 7/20/2013.  Adacel was administered on 7/22/2013. Patient developed an injection site reaction (edema and tenderness to palpation) and fever (maximum temperature was 39) after receipt of Adacel. Empiric antibiotic therapy (gentamicin and Unasyn) were initiated due to fever. Discharged from hospital on 7/23/2013.
polio for the last 15years growing weaker;polio in all limbs except rt arm;homeless, unemployed;1968-surgery post polio-1992 sequela;
Swollen and sore under arm pit are the same side FLU shot was given one day later
After 3 days patient experienced shoulder pain and has had ever since. Doctor's office recommended icing shoulder and TYLENOL or MOTRIN, which patient just started today. Couldn't get in to be seen at Doctor's office.
10:15 am Started to sweat,10:25 am Started to have the chills (chills and sweats traded off throughout the day and night),11:30 am migraine began to progressively get worse and continued throughout the day, 12:00 pm became slightly nauseous ate a little bit of food and it helped. Nausea gone by 12:.35 pm, (progressively slightly more fatigued than normal lasted for 2 days). Night sweats and chills throughout the night and migraine lasted until Thursday.
She first began complaining of tailbone pain. Xray, Ultrasound, MRI and blood work all came back normal but her pain worsened and spread to her entire back. It is extremely painful to the touch. She was diagnosed with Complex Regional Pain Syndrome but now her joints are effected as well. She continues to be in constant pain and has an overall sense of weakness and lethargy that is impacting her daily life.
Developed <12 erythematous papular lesions. 2-3 were at injection site. Others widely distributed. Developed from 2-17 days after vaccination. No actual vesicles.
Patient age at vaccination: 11 years; Sore arm; This is a spontaneous report from a contactable consumer. A 11-year-old patient of an unknown gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on an unknown date in Sep2021 (age at vaccination: UNKNOWN) as a single dose for COVID-19 immunisation. Medical history included asthma; allergy to nuts and egg. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified asthma inhaler taken for asthma from an unknown date and unknown if ongoing; and unspecified allergy medication taken for an unspecified indication from an unknown date and unknown if ongoing. On an unknown date in Sep2021, the patient experienced sore arm. The event did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was resolved on an unknown date in Sep2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever up to 103, chills, body aches all over, fatigue lasting 3 days, and still comes on and off, the fatigue is still persisting til today, several months later
about 25 minutes after the injection pt felt flushed with mild tachycardia and headache.  Pt improved with rest on the exam table.  Bp returned to normal immediately and bp remained normal at 126/84.   Pt returned to work but sx reoccurred about 30 minutes later and she again rested with resolution of sx until she went home.